Circulating Programmed Death Ligand-1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)

被引:0
|
作者
Vecchiarelli, S. [1 ]
D'Incecco, A. [2 ]
Minuti, G. [1 ]
Gallo, M. [3 ]
De Luca, A. [3 ]
Landi, L. [1 ]
Bennati, C. [1 ]
Spreafico, M. [4 ]
D'Arcangelo, M. [1 ]
Attilia, L. [1 ]
Mazza, V. [1 ]
Normanno, N. [3 ]
Cappuzzo, F. [1 ]
机构
[1] Ausl Romagna, Oncohematol Dept, Ravenna, Italy
[2] Univ Hosp Siena, Ctr Immunooncol, Siena, Italy
[3] Fdn Giovanni Pascale, Ircc, Inst Nazl Tumori, Cell Biol & Biotherapy Unit, Naples, Italy
[4] Ist Sci Romagnolo Studio & Cura Tumori Irst, Unit Biostat & Clin Trials, Ravenna, Italy
关键词
Immunotherapy; PD-L1; Non-Small Cell Lung Cancer (NSCLC);
D O I
10.1016/j.jtho.2017.09.1934
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PUB071
引用
收藏
页码:S2389 / S2389
页数:1
相关论文
共 50 条
  • [31] Distribution and Expression of Programmed Death Ligand-1 (PD-L1) in Non-Small Cell Carcinomas of the Lung in a Tertiary Care Centre in South India
    Jacob, Sheba S. K.
    TURKISH JOURNAL OF PATHOLOGY, 2021, 37 (02) : 139 - 144
  • [32] Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancer
    Pan, Yunjian
    Zheng, Difan
    Li, Yuan
    Cai, Xu
    Zheng, Zongli
    Jin, Yan
    Hu, Haichuan
    Cheng, Chao
    Shen, Lei
    Wang, Jian
    Ji, Hongbin
    Sun, Yihua
    Zhou, Xiaoyan
    Chen, Haiquan
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2579 - 2586
  • [33] Molecular Epidemiology of Programmed Cell Death 1-Ligand 1 (PD-L1) Protein Expression in Non-Small Cell Lung Cancer
    Schabath, Matthew
    Dalvi, Tapashi
    Dai, Hongyue
    Crim, Alan
    Midha, Anita
    Shire, Norah
    Walker, Jill
    Greenawalt, Danielle
    Lawrence, David
    Rigas, James
    Brody, Robert
    Potter, Danielle
    Kumar, Naveen
    Huntsman, Shane
    Grays, Jhanelle
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S475 - S476
  • [34] Harmonization of programmed cell death ligand-1 diagnostic assays in non-small cell lung cancer
    Popple, Amy
    Illidge, Timothy M.
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S553 - S556
  • [35] Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Chia, Puey Ling
    John, Thomas
    JOURNAL OF IMMUNOTHERAPY, 2016, 39 (05) : 202 - 204
  • [36] Clinical characteristics of programmed death ligand-1 (PD-L1) positive non-small cell lung cancer patient cohort from a cancer unit - first year experience
    Bulusu, V. R.
    Jeffs, Y.
    Jessop, S.
    Maidment, G.
    Aslam, S.
    LUNG CANCER, 2018, 115 : S40 - S40
  • [37] Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung Cancer
    Inoue, Yusuke
    Yoshimura, Katsuhiro
    Nishimoto, Koji
    Inui, Naoki
    Karayama, Masato
    Yasui, Hideki
    Hozumi, Hironao
    Suzuki, Yuzo
    Furuhashi, Kazuki
    Fujisawa, Tomoyuki
    Enomoto, Noriyuki
    Nakamura, Yutaro
    Asada, Kazuhiro
    Uto, Tomohiro
    Fujii, Masato
    Matsui, Takashi
    Matsuura, Shun
    Hashimoto, Dai
    Toyoshima, Mikio
    Kusagaya, Hideki
    Matsuda, Hiroyuki
    Inami, Nao
    Kaida, Yusuke
    Niwa, Mitsuru
    Ito, Yasuhiro
    Sugimura, Haruhiko
    Suda, Takafumi
    JAMA NETWORK OPEN, 2020, 3 (09) : E2011818
  • [38] Clinicopathological features of programmed cell death ligand 1 (PD-L1) expression in resected non-small cell lung cancers
    Ohhara, Yoshihito
    Kinoshita, Ichiro
    Tomaru, Utano
    Hatanaka, Kanako C.
    Hatanaka, Yutaka
    Honma, Rio
    Takeuchi, Satoshi
    Shimizu, Yasushi
    Kaga, Kichizo
    Matsuno, Yoshihiro
    Dosaka-Akita, Hirotoshi
    CANCER RESEARCH, 2017, 77
  • [39] Programmed cell death ligand-1 (PD-L1) expression combined with CD8 tumor infiltrating lymphocytes density in non-small cell lung cancer patients
    El-Guindy, Dina M.
    Helal, Duaa S.
    Sabry, Nesreen M.
    El-Nasr, Mohamed Abo
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2018, 30 (04) : 125 - 131
  • [40] Adjuvant Chemotherapy Increases Programmed Death-Ligand 1 (PD-L1) Expression in Non-small Cell Lung Cancer Recurrence
    Lacour, Max
    Hiltbrunner, Stefanie
    Lee, Seok-Yun
    Soltermann, Alex
    Rushing, Elisabeth Jane
    Soldini, Davide
    Weder, Walter
    Curioni-Fontecedro, Alessandra
    CLINICAL LUNG CANCER, 2019, 20 (05) : 391 - 396